Evidence map›Paper›PMID 32936333›Full record

ReviewWorld journal of urology2021

Evaluation, diagnosis and surveillance of renal masses in the setting of VHL disease.

Jad Chahoud, Melissa McGettigan, Nainesh Parikh, Ronald S Boris, Othon Iliopoulos, W Kimryn Rathmell, Anthony B Daniels, Eric Jonasch, Philippe E Spiess, International VHL Surveillance Guidelines Consortium-Renal Committee

Open access · greenAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in World journal of urology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
3.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 42 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Hereditary renal mass syndromes: a pictorial review.Abdominal radiology (New York) · 2025
    Review
  7. Article
  8. Monogenic Kidney Diseases in Kidney Transplantation.Kidney international reports · 2024
    Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. FDA Approval Summary: Belzutifan for von Hippel-Lindau Disease-Associated Tumors.Clinical cancer research : an official journal of the American Association for Cancer Research · 2022
    Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Jad ChahoudDepartment of Genitourinary Oncology, H. Lee Moffitt Cancer Center, 12902 Magnolia Dr., Tampa, FL, 33612, USA. Jad.Chahoud@moffitt.org.
Melissa McGettiganDepartment of Diagnostic Imaging and Interventional Radiology, H. Lee Moffitt Cancer Center, 12902 Magnolia Dr., Tampa, FL, 33612, USA.
Nainesh ParikhDepartment of Diagnostic Imaging and Interventional Radiology, H. Lee Moffitt Cancer Center, 12902 Magnolia Dr., Tampa, FL, 33612, USA.
Ronald S BorisDepartment of Urology, Indiana University School of Medicine, Indianapolis, IN, USA.
Othon IliopoulosCenter for Cancer Research, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, 02139, USA.
W Kimryn RathmellDepartment of Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.
Anthony B DanielsDivision of Ocular Oncology and Pathology, Department of Ophthalmology and Visual Sciences, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA.
Eric JonaschDepartment of Genitourinary Medical Oncology, UT MD Anderson Cancer Center, 1515 Holcombe Ave, Houston, TX, 77030, USA.
Philippe E SpiessDepartment of Genitourinary Oncology, H. Lee Moffitt Cancer Center, 12902 Magnolia Dr., Tampa, FL, 33612, USA.
International VHL Surveillance Guidelines Consortium-Renal Committee
Moffitt Cancer Center · USVanderbilt University Medical Center · USIndiana University School of MedicineMassachusetts General Hospital · USThe University of Texas MD Anderson Cancer Center · US

Funding

Chemical Biology of IRP1-HIF2a SignalingR01CA215431 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI ILIOPOULOS, OTHON · 2017 to 2021
$3.1M
Developing alternative approaches to reduce retinal toxicity and prevent vision loss in the treatment of intraocular retinoblastomaK08EY027464 · NEI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DANIELS, ANTHONY BRENT · 2017 to 2021
$960k
National Eye Institute grant NIH/NEI 5K08EY027464-02NCI NIH HHS R01 CA215431NEI NIH HHS K08 EY027464
6 · The paper itself

Abstract

This brief report focuses on the evaluation and diagnosis of clinically localized renal masses in children and adults with Von Hippel-Lindau (VHL) disease. Counseling considerations pertinent to the urologists, medical oncologists, and multidisciplinary teams involved in the care of these patients are addressed. As practice patterns regarding the evaluation and management of VHL tumors can vary considerably, this report aims to provide guidance on some of the controversies associated with the diagnostic evaluation and initial management of localized renal masses in VHL patients.

Indexed as

HumansKidney NeoplasmsPopulation Surveillancevon Hippel-Lindau DiseaseRCCRenal cell carcinomaRenal massVHLVon Hippel–Lindau

Identifiers

PMID32936333
PMCPMC8101019
OpenAlexW3084823027

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.